Literature DB >> 1092283

Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.

A Raskin, T H Crook.   

Abstract

Differential effects of chlorpromazine, imipramine hydrochloride, and a placebo were examined in 159 black and 555 white depressed patients in a multihospital collaborative study. In making these comparisons, the effects of age and social class were controlled. The major study findings were the differential effects of the active drugs for the black men and women. Chlorpromazine was the most efficacious treatment for black women, whereas imipramine was most efficacious for black men. These differences occurred on global ratings of improvement as well as on specific symptoms such as depression, anxiety, guilt-worthlessness, sleep disturbances, and social participation. Black patients also evidenced a higher improvement rate at one week, irrespective of treatment, than did the white patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092283     DOI: 10.1001/archpsyc.1975.01760230109008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  7 in total

1.  Ethnic differences in the neuroleptic treatment of schizophrenia.

Authors:  P Ruiz; R V Varner; D R Small; B A Johnson
Journal:  Psychiatr Q       Date:  1999

2.  A comparison of antidepressant trials using active and inert placebos.

Authors:  Joanna Moncrieff
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

3.  Black and white patients response to antidepressant treatment for major depression.

Authors:  R V Varner; P Ruiz; D R Small
Journal:  Psychiatr Q       Date:  1998

Review 4.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

5.  Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy.

Authors:  Rahn K Bailey; Craig H Mallinckrodt; Madelaine M Wohlreich; John G Watkin; John M Plewes
Journal:  J Natl Med Assoc       Date:  2006-03       Impact factor: 1.798

6.  Race, genetic ancestry and response to antidepressant treatment for major depression.

Authors:  Eleanor Murphy; Liping Hou; Brion S Maher; Girma Woldehawariat; Layla Kassem; Nirmala Akula; Gonzalo Laje; Francis J McMahon
Journal:  Neuropsychopharmacology       Date:  2013-07-05       Impact factor: 7.853

Review 7.  Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis.

Authors:  Sara Ormerod; Sarah E McDowell; Jamie J Coleman; Robin E Ferner
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.